A98.3 Marburg virus disease

Name of the Condition

• Marburg virus disease (ICD-10 Code: A98.3)

Summary

Marburg virus disease is a severe, often fatal viral illness characterized by fever, hemorrhagic manifestations, and multi-organ dysfunction. It is caused by the Marburg virus, a member of the Filoviridae family, and is associated with high mortality rates. The disease can progress rapidly, with severe cases involving shock, coagulopathy, and neurological complications. Outbreaks are typically linked to exposure to infected animal hosts or human-to-human transmission in healthcare settings.

Causes

Marburg virus disease is caused by the Marburg virus, which is transmitted to humans through direct contact with infected animal reservoirs, such as fruit bats, or their bodily fluids. Human-to-human spread occurs via exposure to blood, secretions, or tissues of infected individuals, often in healthcare environments without adequate infection control. The virus can also be transmitted through contaminated surfaces or equipment.

Risk Factors

• Exposure to caves or mines inhabited by fruit bats in endemic regions (e.g., Africa).
• Occupational risks for healthcare workers, laboratory personnel, or those handling animal tissues in outbreak areas.
• Close contact with infected individuals during outbreaks, particularly without personal protective equipment.
• Travel to areas with confirmed Marburg virus activity or recent outbreaks.

Symptoms

• Sudden onset of high fever, chills, and severe headache.
• Muscle and joint pain, fatigue, and abdominal discomfort.
• Nausea, vomiting, and diarrhea, which may be bloody.
• Hemorrhagic manifestations, including petechiae, bruising, or mucosal bleeding.
• In severe cases, shock, organ failure, and neurological symptoms (e.g., confusion, seizures).

Diagnosis

Diagnosis is based on clinical presentation, exposure history, and laboratory testing. Confirmatory tests include reverse transcription-polymerase chain reaction (RT-PCR) for viral RNA, antigen detection, or serology. Samples must be handled under biosafety level 4 (BSL-4) conditions due to the virus's high infectivity. Differential diagnosis includes other viral hemorrhagic fevers (e.g., Ebola) and bacterial sepsis.

Treatment Options

Treatment is primarily supportive, focusing on managing symptoms and complications. This includes fluid resuscitation, electrolyte balance, and treatment of secondary infections. Experimental therapies, such as antiviral medications or monoclonal antibodies, may be used in outbreak settings under investigational protocols. No specific cure exists, and management relies on intensive care.

Prognosis and Follow-Up

Prognosis is poor, with mortality rates ranging from 23% to 90% depending on outbreak strain and healthcare resources. Survivors may experience prolonged recovery, including fatigue, joint pain, and ocular complications. Follow-up care involves monitoring for late-onset sequelae and providing supportive rehabilitation. Isolation precautions are maintained until viral clearance is confirmed.

Complications

• Severe hemorrhage leading to hypovolemic shock.
• Multi-organ failure (e.g., liver, kidney, or respiratory systems).
• Neurological damage, including encephalitis or meningitis.
• Secondary bacterial infections due to immunosuppression.
• Long-term sequelae, such as uveitis or joint pain, in survivors.

Lifestyle & Prevention

• Avoid contact with fruit bats or their habitats in endemic regions.
• Use personal protective equipment (PPE) when caring for infected individuals.
• Practice strict infection control in healthcare settings, including isolation and sterilization of equipment.
• Educate communities on safe burial practices for deceased patients to prevent transmission.
• Report suspected cases to public health authorities immediately.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden fever, severe headache, or unexplained bleeding after potential exposure (e.g., travel to outbreak areas or contact with infected individuals). Healthcare workers should follow institutional protocols for suspected cases and notify infection control teams.

Tips for Medical Coders

Code A98.3 is specific to Marburg virus disease and should be used when documentation confirms the diagnosis. Ensure the code aligns with clinical notes, including exposure history or laboratory confirmation. Avoid using this code for other viral hemorrhagic fevers (e.g., Ebola) or unspecified viral infections. Document any relevant details, such as outbreak context or transmission mode, to support coding accuracy.